AN2 Therapeutics, Inc. is a biopharmaceutical company dedicated to developing therapies to treat rare, chronic, and serious infectious diseases in areas of high unmet needs. Founded by a team of experienced industry leaders in infectious disease drug research and development and boron chemistry, we have a passion for addressing the challenges of infectious disease and improving global human health. For more information, please visit www.an2therapeutics.com.
|
|
|
11-50 employees
View all AN2 Therapeutics employees
|
|
Biotechnology
|
|
1800 El Camino Real, Suite D, Menlo Park, California 94027, US
|
|
2019
|
|
Infectious Disease, Infectious Disease
|
Eric Easom is the CEO of AN2 Therapeutics. To contact Eric Easom email at [email protected] or [email protected]. Or you may call +1.6508049077
The decision makers in AN2 Therapeutics are Alex Smith, Alexander Tung, Sundaravel Ananthavel, etc. Click to Find AN2 Therapeutics decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.